← Back to blog

Executives: 4 Week COA Protocol to Cut Doping Risk in Supplements

September 27, 2026
Executives: 4 Week COA Protocol to Cut Doping Risk in Supplements

Dietary supplements can contain undeclared doping substances and toxic contaminants, and the safest posture is to avoid them unless a clinician prescribes one for a documented need. Antidoping Sverige and Livsmedelsverket both warn consumers directly, and the World Anti-Doping Agency holds athletes strictly liable for anything found in their system. If you currently use a high-risk product, stop and consult a physician before continuing.


TL;DR:

  • Supplements with unfamiliar plant extracts or undisclosed ingredients should be avoided, as they often contain doping substances or toxic contaminants.
  • High-risk categories include pre-workout formulas, fat-burners, and hormone boosters, which frequently hide undisclosed stimulants or anabolic agents.
  • Contamination can occur through cross-contact, unverified raw materials, or deliberate spiking, and testing cannot detect all possible prohibited substances.
  • Using supplements without proper medical oversight increases the risk of liver injury from plant toxins and heavy metal accumulation.
  • For safer use, choose small-batch products with verified batch testing, traceable supply chains, and consult a clinician before starting any supplement.

Viridos
Choose More Disciplined Performance
Viridos supports men in demanding roles with premium Swedish performance products focused on vitality, consistency, and long-term performance longevity.
Explore Viridos

Table of Contents

Types of doping substances hidden in supplement labels

Contamination is not always accidental. Some manufacturers add compounds deliberately to make a product feel effective faster, and the resulting substances range from mild stimulants to compounds that mimic anabolic hormones.

Antidoping Sverige's own case records name specific substances tied to Swedish doping violations, and the pattern repeats across product categories, not just one.

  • Stimulants: methylhexanamine, higenamine, and DMAA appear under trade names that disguise their chemical identity.
  • Designer stimulants: newer synthetic compounds engineered to stay ahead of standard screening panels.
  • Anabolic agents and SARMs: selective androgen receptor modulators marketed as "research chemicals" or muscle-building aids.
  • Undisclosed analogues: chemical cousins of banned substances listed under obscure botanical or Latin names.

A label that lists an unfamiliar plant extract or a compound you cannot easily search is a signal to pause, not proceed, according to Antidoping Sverige's documented cases.

High-risk supplement categories worth extra scrutiny

Not every category carries equal risk. Three types dominate the incident reports and deserve the most caution.

  1. Pre-workout formulas: often built on proprietary blends that hide stimulant doses and undisclosed compounds behind vague ingredient names.
  2. Fat-burners: frequently the source of the most aggressive adulteration, since rapid fat loss is difficult to achieve safely and manufacturers reach for shortcuts.
  3. Hormone or testosterone boosters: marketed with performance language but sometimes containing actual anabolic agents rather than the herbal ingredients on the label.

Any product promising dramatic results in days, or built around an exotic plant extract with limited research, belongs in this same cautious category.

Why contamination happens and why testing can't catch everything

Contamination reaches finished products through several distinct pathways: cross-contact on shared manufacturing lines, impure raw materials sourced from unregulated suppliers, and, in some cases, deliberate spiking to boost perceived effectiveness. Mycotoxins can also form in poorly stored plant material before it ever reaches a factory.

Certificates of analysis and third-party seals lower risk but do not eliminate it. A narrative review published on PMC found that a meaningful share of analyzed supplements contained undisclosed prohibited substances, and no single test screens for every possible analogue. WADA's own laboratory standards make clear that accredited labs do not issue market approval for commercial products, so a lab result is a data point, not a guarantee.

  • Cross-contamination on shared production equipment.
  • Deliberate adulteration to enhance marketed effects.
  • Raw-material impurities from unverified suppliers.
  • Mycotoxin formation in improperly stored botanicals.

Pro Tip: A clean certificate of analysis tells you what was tested, not everything that was present. Ask what the lab screened for, specifically.

Strict liability means an athlete is responsible for anything detected in a sample, regardless of intent, which is why the International Standard for Laboratories exists to standardize detection rather than to certify products as safe.

Health dangers that have nothing to do with a positive test

A clean drug test does not mean a clean bill of health. Several supplement-related harms carry no doping implication at all, yet they carry real medical weight.

Concentrated plant extracts have been linked to liver injury in case reports, and Livsmedelsverket names plant toxins and overdosage among the documented risk categories for supplements generally.

A 2023 Livsmedelsverket report documented mycotoxins including aflatoxins and ochratoxin A in plant-based dried supplements, hazards tied to carcinogenic and genotoxic effects at chronic exposure levels. Dried herbal powders carry this risk more often than synthetic formulations, since fungal contamination develops during storage before processing.

Heavy metals accumulate through the same weak points in raw-material sourcing, and chronic low-level exposure carries its own long-term health cost. Add the possibility of interactions with prescription medications, and the case for medical oversight before starting any supplement becomes difficult to dismiss.

Four supplement health risk categories

Who should avoid supplements entirely

Certain circumstances raise the stakes well beyond ordinary caution. If any of the following apply to you, the calculus shifts firmly toward avoidance.

  • Athletes under drug testing, or professionals subject to workplace testing where strict liability applies.
  • Pregnant or breastfeeding individuals, and anyone managing liver or kidney disease.
  • Anyone taking prescription medications with known interaction risks.
  • Older adults managing multiple medications, where added compounds complicate an already delicate balance.
  • Anyone preparing for surgery or a medical procedure where bleeding risk or organ function is a concern.

How to reduce risk if you choose to use a supplement

If avoidance is not realistic for your situation, a disciplined process narrows the exposure considerably. Follow these steps in order, not selectively.

  1. Start with a clinical assessment. Use supplementation only for a documented deficiency or under direct clinician guidance, never on assumption.
  2. Cross-reference every ingredient against WADA and Antidoping Sverige's published substance lists, watching for alternate chemical or trade names.
  3. Demand a batch-specific certificate of analysis from an accredited laboratory, not a generic product-level document. A five-step COA check gives executives a practical framework for this.
  4. Favor traceable, small-batch producers with documented supply chains over mass-market brands with opaque sourcing.
  5. Never introduce a new product close to competition or a testing window. Trial any product during training, at a conservative dose, and keep a dated log.
  6. Stop immediately if anything feels wrong, and seek medical advice. Keep copies of every COA and supplier communication.

Pro Tip: A dated supplement log, kept even for products you consider low-risk, becomes the evidence that protects you if a question ever arises.

What disciplined verification looks like in practice

What disciplined verification looks like in practice — overview diagram

A conservative trial protocol reduces both health and reputational exposure without requiring you to abandon supplementation altogether. Joakim recommends a four-week trial window: begin at a low dose, monitor relevant blood markers where applicable, and build in a documented stop period before any drug test or high-stakes commitment.

Before that trial begins, five supplier checks separate a traceable product from a guess:

  • Batch number matched precisely to the certificate of analysis you were given.
  • Laboratory accreditation confirmed independently, not taken from the seller's word.
  • Raw-material origin disclosed, not hidden behind a proprietary blend.
  • Stability data showing the product performs as tested over its shelf life.
  • Chain-of-custody documentation connecting raw material to finished batch.

Small-batch, membership-managed production narrows the number of unknowns in a supply chain compared with mass-market manufacturing, where volume often outpaces oversight. Further detail on interpreting these documents appears in Viridos' guide to third-party testing limits.

A disciplined man's view on supplement risk

Most performance gains from supplements are marginal, and most doping incidents trace back to products that promised more than biology allows. Weighed against the reputational, legal, and health cost of a positive test or a liver injury, the math rarely favors the shortcut.

The discipline that built your career applies here too: evidence first, documentation always, and clinician involvement before ambition.

— Joakim

A managed alternative for executives who want fewer unknowns

If you have decided supplementation has a place in your regimen, the same scrutiny you apply to a business decision should apply here. Membership access limits volume, and small-batch Swedish production aims to reduce supply-chain unknowns.

Viridos

  • Batch testing is enforced as a structural part of production, not an afterthought.
  • Membership access limits volume, which keeps traceability intact from raw material to finished product.
  • The approach is a managed route, not a guarantee against every possible risk.

We recommend a conversation with your physician before enrolling in any supplement program, including ours. Review Member and Professional plans to see whether a traceable approach fits your standards.

Where to verify claims and check products yourself

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

Sources

FAQ

Which supplements are linked to a higher cancer risk?

No supplement is established as a direct cancer cause, but certain contaminants raise concern. Livsmedelsverket's 2023 report found mycotoxins such as aflatoxins and ochratoxin A in plant-based dried supplements, both classified as carcinogenic hazards at chronic exposure levels.

What are the main risks associated with dietary supplements?

The main risks include undeclared doping substances, plant toxins, heavy metals, microbial and mycotoxin contamination, and overdosage, according to Livsmedelsverket. Athletes face the added risk of strict liability if any prohibited substance turns up in testing, regardless of intent.

Why should supplement use generally be avoided?

Supplements fall outside the approval and testing rigor applied to medicines, so quality and purity vary widely between products and even between batches. A narrative review on PMC found that a notable share of analyzed products contained undisclosed prohibited substances, which makes avoidance the safer default unless a clinician has confirmed a specific need.

Which supplements pose the greatest risk to liver health?

Concentrated botanical extracts carry the strongest documented links to liver injury in case reports and clinical surveillance. Products combining multiple plant compounds in a proprietary blend make it harder to identify which ingredient caused harm, which is part of why Antidoping Sverige and Livsmedelsverket both flag undeclared botanical content as a distinct risk category.